Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott(Shriners Hospitals for Children - Erie), Mehmet Toner(Center for Cancer Research), S. Michael Rothenberg(Pfizer (United States)), Belinda A. Waltman(Harvard University), Chia‐Hsien Hsu, Daniel Winokur(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Min Yu(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Dina Tsukrov(Harvard University), Simeon Springer(Howard Hughes Medical Institute), Malgorzata E. Smas(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Anna J. Gilman(Harvard University), Frederick P. Floyd(Harvard University), Lecia V. Sequist(Harvard University), Daniel Irimia(Shriners Hospitals for Children - Erie), Kurt J. Isselbacher(Harvard University), Ajay M. Shah(University of Wales), George K. Korir(Harvard University), Sunitha Nagrath(University of Michigan), Jenna B. Lord(Harvard University), David T. Miyamoto(Broad Institute)
Cited by 1,626
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k